Log In
Print
BCIQ
Print
Print this Print this
 

ASP8232

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionUndisclosed oral compound
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today